跳至主要内容
临床试验/DRKS00025259
DRKS00025259招募中不适用

Register study on neuroprognostics in patients with neurological / neurosurgical diseases in intensive care unit - NeuProg

Klinik für Neurologie mit experimenteller Neurologie der Charité Universitätsmedizin Berlin, Campus Charité Mitte0 个研究点目标入组 1,700 人开始时间: 2021年5月6日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
1,700

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • 18 years and older
  • - Neurointensive medical condition requiring monitoring in the neurointensive care unit or stroke unit. This applies to patients with the following diagnoses: ischaemic stroke, intracerebral haemorrhage, subarachnoid haemorrhages, neurovascular malformations, craniocerebral trauma, brain tumours, Infectious diseases of the nervous system (pathogen-induced meningitis/encephalitis), neuromuscular diseases (e.g. myastenia grasvis, Lambert-Eaton syndrome), Various autoimmune neurological diseases (e.g. autoimmune encephalitis, multiple sclerosis, myelitis, neuromyelitis optica, inflammatory neuropathies (GBS, CIDP), myopathies/myositis), Metabolic or genetic neurological diseases, Hypoxic-ischaemic encephalopathies after cardiac arrest, Metabolic encephalopathies, Seizure disorders (status epilepticus, other epileptic seizures), Neurodegenerative diseases (e.g. ALS, Parkinson's disease, multisystem atrophies, Huntington's disease), Quantitative and qualitative disorders of consciousness (e.g. delirium), Intoxications
  • - Consent by the patient or the patient's legal representative

排除标准

  • - Simultaneous participation in an interventional drug or medical device study.
  • - Known contraindications to MRI (pacemakers, neurostimulators, metal splinters, cochlear implant, claustrophobia)

研究者

发起方
Klinik für Neurologie mit experimenteller Neurologie der Charité Universitätsmedizin Berlin, Campus Charité Mitte

相似试验